Every parliamentary written question tabled by Lee Pitcher this session, with the full answer and department. See how every department answers, or back to the MP page.
Showing 21–40 of 90 · this parliament
If the Government will introduce legislation relating to the statutory regulation of the enforcement sector before the end of this Parliament.
The Government supports the work of the Enforcement Conduct Board to make sure anyone facing enforcement action is treated properly. Following our consultation about statutory independent regulation of the sector, we have worked on proposals to ensure fai...
What data the Department holds on the average age at (a) initiation of dopamine agonist therapy, (b) first report or diagnosis of an impulse control disorder while taking a dopamine agonist and (c)
Awaiting answer.
What information national pharmacovigilance systems and clinical datasets provide on the range and relative frequency of withdrawal symptoms associated with dopamine agonist discontinuation, includ
Awaiting answer.
What data national bodies hold on (a) the number and proportion of people prescribed dopamine agonists who self-report impulse control disorders and (b) the number and proportion whose impulse cont
Awaiting answer.
What data the Department holds on the proportion of patients with restless legs syndrome treated with dopamine agonists who have co-existing neurodevelopmental or psychiatric diagnoses, including a
Awaiting answer.
What assessment the Department has made of the levels of (a) sexually transmitted infections acquired in the context of dopamine agonist-induced hypersexuality and (b) unplanned pregnancies among w
Awaiting answer.
Whether his Department has made an assessment of the effectiveness of how dopamine agonist-related impulse control disorders and augmentation are taught and assessed in undergraduate medical educat
Awaiting answer.
What guidance is issued to clinicians on discussing in advance with patients, and where appropriate their families, how treatment should be managed if severe impulse control disorders develop while
Awaiting answer.
What assessment his Department has made of the use of artificial intelligence and digital tools within the NHS and the Medicines and Healthcare products Regulatory Agency to (a) detect potential do
Awaiting answer.
What data the Department holds on (a) the number and proportion of dopamine agonist-treated patients who report binge eating or marked weight gain, (b) weight and metabolic monitoring practices whe
Awaiting answer.
What assessment the Department has made of the level of suicides and attempted suicides among (a) people prescribed dopamine agonists who have experienced impulse control disorders, augmentation or
Awaiting answer.
What evidence the Department has assessed on the average time from initiating a dopamine agonist, or increasing its dose, to (a) the onset or first report of impulse control disorder symptoms and (
Awaiting answer.
What assessment the Department has made of risk factors for dopamine agonist-induced impulse control disorders, including age, renal impairment, duration of exposure, cumulative dose, polypharmacy,
Awaiting answer.
What evidence the Department has assessed on the number and proportion of patients who develop impulse control disorders while taking dopamine agonists and subsequently (a) continue dopamine agonis
Awaiting answer.
What information his Department holds on (a) the likelihood of patients who develop one dopamine agonist-associated impulse control disorder developing additional impulse control disorders and (b)
Awaiting answer.
What data the Department holds on the proportion of patients with restless legs syndrome alone, compared with patients with restless legs syndrome and attention deficit hyperactivity disorder, auti
Awaiting answer.
What data the Department holds on (a) the average length of time patients remain on dopamine agonists or partial dopamine agonists for each licensed indication, (b) the proportion of patients who r
Awaiting answer.
Whether his Department holds audit or research data on differences between neurology or movement disorder specialists and general practitioners in (a) warning patients and families about dopamine a
Awaiting answer.
What data the Department holds on the number and proportion of dopamine agonist-treated patients with impulse control disorders who experience relationship breakdown or divorce.
Awaiting answer.
What assessment his Department has made of the potential impact of dopamine agonist-related impulse control disorders and augmentation in people with restless legs syndrome and Parkinson’s disease
Awaiting answer.